Andrew Hore @Hubinvest Quoted Micro 25 November 2019 #FDBK #NMRP #WESP #BILB #SAPO #BRAC #ANR #BWAP #BLCC #DXSP #LIFE #BRY #IDH #WINE #KAPE #MANO #STRL #FPO #NTOG #CIP #CIN #MIRA #XSG #PPG #MPM #CML #MACF #TRI #RBW #KCT #MVI #stockstowatch #microcaps

RNS Number: 8175 T Feedback PLC 19 November 2019 Feedback plc. Cambridge, 19 November 2019: Feedback plc announces that at the annual general meeting of the Company held on 18 November 2019, all resolutions were duly passed on a show of hands. The proxy voting results of the resolutions are included below.. RNS is approved by the Financial Conduct Authority to act as...

Cambridge, 18 November 2019: Feedback plc, the specialist medical imaging technology company, provides the following update ahead of its Annual General Meeting, which is being held today at 3 pm at the offices of Peterhouse Corporate Finance Limited, 80 Cheapside, London, EC2V 6 EE.. We have received interest from clinicians and professionals across both public...

RNS Number: 6592 T Feedback PLC 18 November 2019 Feedback plc. Bleepa ® pilot study- The Pennine Acute Hospitals NHS Trust, part of the Northern Care Alliance, to initiate a pilot study using Bleepa ®. Pilot study to be used initially by respiratory teams to receive internal patient referrals.

Alan Green CEO of Brand Communications discusses Feedback #FDBK and gives the bull case for Metro Bank (UK) #MTRO on the Vox Markets #podcast with Justin Waite. #Banking #stockstowatch #StocksToTrade

TexRAD achieved new contracts from Korea and the USA.. Reported revenue up 23% to £563,092 driven from existing product lines. Loss before tax of £1.13 million due to changes in accounting practices and increased investment in staff as the Company gears up to deliver its new products and strategic direction.

Feedback (FDBK) 1.40p £6.5m Feedback, the specialist medical imaging technology company, provides an update on Bleepa®. The Company is considering a number of potential opportunities for Bleepa® following its launch at the NHS Expo in September 2019. The Company is in advanced discussions with NHS pilot sites whilst additionally pursuing a number of commercial opportunities within and outside the NHS, and hopes to commence Bleepa® pilot schemes in the near future.

Feedback Plc (FDBK.L) Announced an update on Bleepa, that the company is considering a number of potential opportunities for Bleepa following its launch at the NHS Expo in September 2019. The company is in advanced discussions with NHS pilot sites whilst additionally pursuing a number of commercial opportunities within and outside the NHS and hopes to commence Bleepa pilot schemes in the near future. To date, the Bleepa product has been well received by the healthcare community and the company believes that it will enable a number of healthcare providers to provide faster, safer, more efficient care. The company looks forward to providing further updates in due course

RNS Number: 1508 Q Feedback PLC 17 October 2019 Feedback plc. Cambridge, 17 October 2019: Feedback plc, the specialist medical imaging technology company, is pleased to provide an update on Bleepa ®.. The Company is considering a number of potential opportunities for Bleepa ® following its launch at the NHS Expo in September 2019.

Cambridge, 27 September 2019: Feedback plc notes the movement in the share price today. The Company notes the announcement earlier today by IQ-AI Ltd that Imaging Biometrics, IQ-AI's Milwaukee based subsidiary, today received notification that the FDA has cleared StoneChecker Software for marketing in the USA. Feedback Medical works with customers...

Feedback Plc (FDBK.L) Announced that it is unveiling its new revolutionary clinical messaging product, Bleepa, to over 6,000.00 conference delegates at NHS Expo in Manchester on 4-5 September 2019. Bleepa is an innovative new app based on Feedback's Cadran technology, which allows medical staff to securely view and discuss high quality medical grade images on mobile devices. The app will display images directly from the hospital's Picture Archive Communication System (PACS). The Directors of the company believe Bleepa will be the leading communication tool on the market and will be a CE marked medical device.

RNS Number: 1146 L Feedback PLC 04 September 2019 Feedback plc. Bleepa™- the revolutionary clinical messaging app- showcased at NHS Expo 2019. Feedback Medical unveils ground-breaking medical imaging product.

RNS Number: 0432 L Feedback PLC 03 September 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.

RNS Number: 9137 K Feedback PLC 02 September 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.

RNS Number: 7841 K Feedback PLC 02 September 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.

RNS Number: 6246 K Feedback PLC 30 August 2019 Feedback plc. Cambridge, 30 August 2019: Feedback plc announces that the Company's issued share capital, as at the date of this announcement, comprises 539,949,917 ordinary shares, with one voting right per share. Feedback Medical works with customers globally from headquarters in the internationally renowned...

RNS Number: 6007 K Feedback PLC 29 August 2019 Feedback plc. Cambridge, 29 August 2019: Feedback plc announces that at the general meeting of the Company held earlier today, all resolutions were duly passed, including resolutions 1 and 2 pertaining to the Company's placing and subscription.. The proxy voting results of the resolutions are included below:.

Feedback Plc (FDBK.L) Announced the appointment of Professor Rory Shaw as non-executive Deputy Chairman of the company, effective immediately. Meanwhile, Dr Alastair Riddell, non-executive Chairman, has informed the company that he intends to retire at the company's next annual general meeting.